|
|
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax (Anthrax Vaccine Adsorbed), is licensed by the U.S. Food and Drug Administration for the prevention of anthrax. Emergent’s development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia.
Ticker: |
EBS |
ISIN: |
US29089Q1058 |
Address: |
2273 Research Boulevard Suite 400, USA, Rockville MD, 20850 |
Website: |
Emergent BioSolutions |
Phone Number: |
301-7951800 |
|
Basic corporate social responsibility ratingsData sources for this companyRatings history Subcategory CSR ratingsSpecial issues that affect this company
Name variants
|
|